Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 344,021	$ 188,480
Short-term investments	225,107	130,291
Restricted cash (SRX Cardio)	170	178
Prepaid research and development	1,888	7,299
Prepaid expenses and other current assets	8,766	2,680
Total current assets	579,952	328,928
Property and equipment, net	5,614	6,143
Intangible assets	7,996	3,151
Long-term investments	28,625
Prepaid and other long-term assets	9,609	5,214
Total assets	631,796	343,436
Current liabilities:
Accounts payable	17,463	14,546
Accrued compensation and employee benefits	8,910	4,806
Accrued research and development	24,144	23,818
Accrued and other liabilities	4,065	1,696
Deferred revenue, current portion	15,187	20,798
Total current liabilities	69,769	65,664
Notes payable, long-term	52,505	49,815
Long term debt	52,388
Long term obligation to Collaborator	8,000	8,000
Deferred revenue, long-term	17,833	24,965
Other long-term liabilities	2,912	2,303
Total liabilities	203,407	150,747
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.001 par value, 100,000,000 shares authorized at September 30, 2017 and December 31, 2016; 65,217,575 shares and 56,544,218 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	67	57
Additional paid-in capital	1,538,583	1,108,832
Accumulated deficit	(1,112,571)	(918,345)
Accumulated other comprehensive loss	(37)	(12)
Total Portola stockholders’ equity	426,042	190,532
Noncontrolling interest (SRX Cardio)	2,347	2,157
Total stockholders’ equity	428,389	192,689
Total liabilities and stockholders’ equity	$ 631,796	$ 343,436